Diploma LON: DPLM reported 45% earnings per share growth for fiscal 2026 and forecast another year of revenue and earnings growth, although management expects margins and the pace of organic growth to moderate.
The company said revenue rose 21%, including 15% organic growth and a 6% contribution from acquisitions. Operating profit increased 42% to £487 million, while earnings per share rose to £2.556. The operating margin expanded by 400 basis points to 26.5%.
Chief Financial Officer Wilson Ng said the company’s performance benefited from higher volumes, which supported operating leverage, as well as its ability to pass on input cost increases through pricing.
2027 outlook points to slower growth
For fiscal 2027, Diploma expects organic revenue growth of 6%, above its financial model of 5%. Acquisitions completed to date are expected to add another 6% to revenue growth, with any further deals providing an additional contribution.
The company guided to a 25.5% operating margin, down from 26.5% in 2026, and said it expects further earnings per share growth. Ng attributed the expected margin moderation to investment in operating expenses, dilution from acquisitions and a controlled reduction in margins at Peerless, while that business continues to grow profit.
Ng said the acquisitions made to date have an average operating margin of 21%. He also said Peerless’ margin is expected to settle in the low 40% range over time.
Diploma anticipates double-digit organic growth in the first quarter, followed by slower growth in the second and third quarters as it compares with particularly strong periods a year earlier. Ng said the company entered the year with strong momentum, but noted that working-day patterns and the timing of Easter could also affect quarterly comparisons.
Controls leads sector growth
Controls delivered 25% organic growth in 2026, supported by businesses including Peerless, Clarendon and IS Group. Windy City also grew strongly, with volume and copper price pass-through contributing roughly equally.
Ng said Windy City grew 19% last year, with approximately half of that growth benefiting from copper pricing. He said some recent softening in copper prices could slightly reduce revenue growth in the coming year, but would have a negligible impact on profit.
Seals posted 4% organic growth for the full year, with growth improving to 6% in the second half. North American Seals achieved high single-digit organic growth, while international markets were challenging earlier in the year but improved later.
Life Sciences recorded 1% organic growth as healthcare markets remained difficult and more products than usual reached the end of their life cycles. Ng said the sector nevertheless increased revenue by 12% and profit by 15%, helped by acquisitions and margin improvement. He said the near term would remain challenging, but described the product pipeline as healthy.
Acquisitions and cash deployment
Diploma said it completed 16 acquisitions from the start of fiscal 2026 through the early part of fiscal 2027, investing £368 million and adding approximately £50 million of annualized operating profit. The deals include CDM, a U.S. defense business acquired for $170 million, and Elite, a U.S. supplier of water pump parts bought after the year-end for $90 million.
Ng said CDM and Elite together contribute more than £20 million of annualized operating profit. The company said its acquisition pipeline remains healthy, while management noted that competition for quality businesses can make deals expensive.
Free cash flow was £323 million, with cash conversion of 94%. Diploma deployed almost £60 million mainly on targeted inventory investments and expects cash conversion to be around 90% in future, rather than at the higher levels seen in recent years.
Net debt rose to £351 million, while leverage remained at 0.7 times. Return on capital was 25.3%, and the dividend increased by 5%. Ng said returns are expected to moderate over time toward the company’s preferred high-teens range as it continues to invest and pursue acquisitions.
About Diploma (LON:DPLM)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.